Erkan Elif, Garcia Clotilde D, Patterson Larry T, Mishra Jaya, Mitsnefes Mark M, Kaskel Frederick J, Devarajan Prasad
Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.
J Am Soc Nephrol. 2005 Feb;16(2):398-407. doi: 10.1681/ASN.2003100861. Epub 2004 Dec 15.
The hypothesis that apoptosis represents a proximate mechanism by which tubule cells are damaged in FSGS was tested. Thirty kidney biopsy specimens from children with idiopathic early FSGS were studied retrospectively. Unexpected, apoptosis was evident in both proximal and distal tubule cells. There was a significant correlation between the degree of proteinuria and the number of apoptotic cells. Fas protein was detected predominantly in the tubule cells that underwent apoptosis. When compared with patients with other chronic proteinuric states, those with FSGS displayed a proliferation/apoptosis ratio in favor of proliferation in the glomerulus but dramatically in favor of apoptosis in the tubules. When both proteinuria and apoptosis were included in a stepwise logistic regression procedure, only apoptosis was found to predict independently the development of ESRD. Prolonged incubation of cultured Madin-Darby canine kidney (distal/collecting) cells with albumin also resulted in a dose- and duration-dependent induction of apoptosis and activation of the Fas pathway, lending support to the novel finding of distal tubule cell apoptosis in patients with FSGS. The results indicate that an elevated tubule cell apoptosis rate at the time of initial biopsy represents an independent predictor of progression to ESRD in patients with early FSGS.
对凋亡是局灶节段性肾小球硬化(FSGS)中肾小管细胞受损的一种直接机制这一假说进行了检验。对30例特发性早期FSGS患儿的肾活检标本进行了回顾性研究。出乎意料的是,近端和远端肾小管细胞中均有明显的凋亡现象。蛋白尿程度与凋亡细胞数量之间存在显著相关性。Fas蛋白主要在发生凋亡的肾小管细胞中检测到。与其他慢性蛋白尿状态的患者相比,FSGS患者的增殖/凋亡比在肾小球中有利于增殖,但在肾小管中则显著有利于凋亡。当将蛋白尿和凋亡纳入逐步逻辑回归程序时,发现只有凋亡能够独立预测终末期肾病(ESRD)的发生。用白蛋白对培养的马-达二氏犬肾(远端/集合)细胞进行长时间孵育,也导致了剂量和时间依赖性的凋亡诱导以及Fas途径的激活,这支持了FSGS患者远端肾小管细胞凋亡这一新发现。结果表明,初次活检时肾小管细胞凋亡率升高是早期FSGS患者进展为ESRD的一个独立预测指标。